Yong Qing Cheng
Chief Executive Officer at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profile
Yong Qing Cheng is the Chairman & General Manager of Beijing Tri Prime Gene Pharmaceutical Co., Ltd., which he founded in 1992.
He holds an MBA from China Europe International Business School, a graduate degree from Peking Union Medical College, and an undergraduate degree from West China School of Pharmacy.
Yong Qing Cheng active positions
Companies | Position | Start |
---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Chief Executive Officer | 1992-09-23 |
Training of Yong Qing Cheng
China Europe International Business School | Masters Business Admin |
Peking Union Medical College | Graduate Degree |
West China School of Pharmacy | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
Health Technology |
- Stock Market
- Insiders
- Yong Qing Cheng